is up 13% — almost double the broader health-care space. Cornerstone Macro's Carter Worth says the biotech breakout isn't over yet.
"The 150-day moving average is actually inflecting upward for the first time in about two-plus years," he said. That's an appealing setup to my eye, and I think it's a good place to be long in an otherwise languishing area of the market."
Have your stupid biotech wave while you can before we get some more humans in office to legalize studying cannabis and other unstudied drugs.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
منبع: Forbes - 🏆 394. / 53 ادامه مطلب »